Correlation Between ZyVersa Therapeutics and BioLineRx

Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and BioLineRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and BioLineRx into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ZyVersa Therapeutics and BioLineRx, you can compare the effects of market volatilities on ZyVersa Therapeutics and BioLineRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of BioLineRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and BioLineRx.

Diversification Opportunities for ZyVersa Therapeutics and BioLineRx

0.16

Correlation Coefficient

ZyVersa Therapeutics  BioLineRx

Average diversification

The 3 months correlation between ZyVersa and BioLineRx is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and BioLineRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLineRx and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with BioLineRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLineRx has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and BioLineRx go up and down completely randomly.

Pair Corralation between ZyVersa Therapeutics and BioLineRx

Given the investment horizon of 90 days ZyVersa Therapeutics is expected to generate 0.76 times more return on investment than BioLineRx. However, ZyVersa Therapeutics is 1.31 times less risky than BioLineRx. It trades about -0.09 of its potential returns per unit of risk. BioLineRx is currently generating about -0.13 per unit of risk. If you would invest  117.00  in ZyVersa Therapeutics on December 22, 2024 and sell it today you would lose (42.00) from holding ZyVersa Therapeutics or give up 35.9% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

ZyVersa Therapeutics  vs.  BioLineRx

ZyVersa Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

BioLineRx

Risk-Adjusted Performance

Very Weak

Over the last 90 days BioLineRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with ZyVersa Therapeutics and BioLineRx

The main advantage of trading using opposite ZyVersa Therapeutics and BioLineRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, BioLineRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLineRx will offset losses from the drop in BioLineRx's long position.

The idea behind ZyVersa Therapeutics and BioLineRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.